Drug Shortage Report for SANDOZ ZOLMITRIPTAN ODT
Report ID | 225976 |
Drug Identification Number | 02362996 |
Brand name | SANDOZ ZOLMITRIPTAN ODT |
Common or Proper name | ZOLMITRIPTAN ODT |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | ZOLMITRIPTAN |
Strength(s) | 2.5MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL ORAL |
Packaging size | 2ODT |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-04-23 |
Estimated end date | 2025-05-02 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-09-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2024-09-09 | French | Compare |
v10 | 2024-09-09 | English | Compare |
v9 | 2024-07-22 | French | Compare |
v8 | 2024-07-22 | English | Compare |
v7 | 2024-06-12 | French | Compare |
v6 | 2024-06-12 | English | Compare |
v5 | 2024-06-03 | French | Compare |
v4 | 2024-06-03 | English | Compare |
v3 | 2024-04-24 | English | Compare |
v2 | 2024-04-23 | French | Compare |
v1 | 2024-04-23 | English | Compare |
Showing 1 to 11 of 11